<code id='6CE770C837'></code><style id='6CE770C837'></style>
    • <acronym id='6CE770C837'></acronym>
      <center id='6CE770C837'><center id='6CE770C837'><tfoot id='6CE770C837'></tfoot></center><abbr id='6CE770C837'><dir id='6CE770C837'><tfoot id='6CE770C837'></tfoot><noframes id='6CE770C837'>

    • <optgroup id='6CE770C837'><strike id='6CE770C837'><sup id='6CE770C837'></sup></strike><code id='6CE770C837'></code></optgroup>
        1. <b id='6CE770C837'><label id='6CE770C837'><select id='6CE770C837'><dt id='6CE770C837'><span id='6CE770C837'></span></dt></select></label></b><u id='6CE770C837'></u>
          <i id='6CE770C837'><strike id='6CE770C837'><tt id='6CE770C837'><pre id='6CE770C837'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:42357
          A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

          Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

          Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron. 

          advertisement

          “It has been exciting to be involved,” Gorham wrote. 

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          STAT letters to the editor on burnt
          STAT letters to the editor on burnt

          MollyFergusonforSTATSTATnowpublishesselectedLetterstotheEditorreceivedinresponsetoFirstOpinionessays

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          After sickle

          MollyFerguson/STATTheapprovalFridayofBluebirdBio’sgenetherapyforsicklecelldiseaseshouldhavebeenamome